Pharma Reviews: Global pharma sales face $60 bn hit due to pricing scrutiny: market study

The report states that patent expiries of drugs worth 194 billion will erode the sales of multinational pharma companies but will benefit Indian drug ...
Read more: Global pharma sales face $60 bn hit due to pricing scrutiny: market study